Sertraline Hydrochloride | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Sertraline Hydrochloride
EDQM

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

Inke S.A: APIs manufacturing plant.

Contact Supplier

xyz-pharma-m-2025-04-21

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

xyz-pharma-m-2025-04-14

Contact Supplier

Sertraline Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

84 API Suppliers, 25 USDMF, 25 CEP/COS, 7 JDMF, 22 EU WC, 15 KDMF, 15 NDC API, 34 Listed Suppliers, $ API Reference Price

84 API Suppliers
25 USDMF
25 CEP/COS
7 JDMF
22 EU WC
15 KDMF
15 NDC API
34 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

17 Intermediate Suppliers

17 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

557 FDF Dossiers, 96 FDA Orange Book, 255 Europe, 54 Canada, 68 Australia, 25 South Africa, 59 Listed Dossiers

557 FDF Dossiers
96 FDA Orange Book
255 Europe
54 Canada
68 Australia
25 South Africa
59 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 25MG BASE, TABLET;ORAL - EQ 50MG BASE

TABLET;ORAL - EQ 100MG BASE
TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 25MG BASE
TABLET;ORAL - EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 SPI Pharma, 5 DKSH, 5 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 23 BASF, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 12 Sigachi Industries, 4 Silverline Chemicals, 1 Symrise, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

71 Fillers, Diluents & Binders, 52 Coating Systems & Additives, 31 Controlled & Modified Release, 28 Disintegrants & Superdisintegrants, 26 Solubilizers, 26 Direct Compression, 24 Thickeners and Stabilizers, 22 Granulation, 20 Film Formers & Plasticizers, 20 Topical, 16 Parenteral, 16 Lubricants & Glidants, 12 Co-Processed Excipients, 8 Taste Masking, 8 Emulsifying Agents, 7 API Stability Enhancers, 7 Rheology Modifiers, 6 Chewable & Orodispersible Aids, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Surfactant & Foaming Agents

71 Fillers, Diluents & Binders
52 Coating Systems & Additives
31 Controlled & Modified Release
28 Disintegrants & Superdisintegrants
26 Solubilizers
26 Direct Compression
24 Thickeners and Stabilizers
22 Granulation
20 Film Formers & Plasticizers
20 Topical
16 Parenteral
16 Lubricants & Glidants
12 Co-Processed Excipients
8 Taste Masking
8 Emulsifying Agents
7 API Stability Enhancers
7 Rheology Modifiers
6 Chewable & Orodispersible Aids
5 Empty Capsules
4 Vegetarian Capsules
4 Coloring Agents
3 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 28 News #PharmaBuzz

1 Data Compilation #PharmaFlow
28 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 217 Regulatory FDF Prices, 9 Annual Reports

2 US Medicaid Prescriptions
217 Regulatory FDF Prices
9 Annual Reports

MARKET PLACE

17 APIs, 6 FDF Dossiers

17 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 Health Canada Patents

5 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 2 USP, 15 Others

4 EDQM
2 USP
15 Others

ANALYTICAL

1 Analytical Methods

1 Analytical Methods

$ API Ref.Price (USD/KG) : 125 Xls

Filters

Reset all filters

Filters

FILTER :

filter Order Code Reset all filters

4 All

01 1Y0000828

02 1Y0000866

03 1Y0000867

04 1Y0001285

filter CAS Number Reset all filters

4 All

01 1611-71-2

02 379559-97-0

filter Reference Standard Reset all filters

4 All

01 1Sertraline for peak identification

02 1Sertraline for system suitability

03 1Sertraline hydrochloride

04 1Sertraline impurity E

Product Main Page

01

EDQM, Council of Europe

Sertraline hydrochloride

Iran Expo

Not Confirmed

01

EDQM, Council of Europe

Iran Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Sertraline hydrochloride

CAS Number : 79559-97-0

Quantity Per Vial : 200 mg

Sale Unit : 1

Order Code : Y0000828

Batch No : 3

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EDQM, Council of Europe

Sertraline impurity E

Iran Expo

Not Confirmed

02

EDQM, Council of Europe

Iran Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Sertraline impurity E

CAS Number : 611-71-2

Quantity Per Vial : 15 mg

Sale Unit : 1

Order Code : Y0001285

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EDQM, Council of Europe

Sertraline for peak identification

Iran Expo

Not Confirmed

03

EDQM, Council of Europe

Iran Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Sertraline for peak identification

CAS Number : 79559-97-0

Quantity Per Vial : 5.4 mg

Sale Unit : 1

Order Code : Y0000866

Batch No : 5

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

EDQM, Council of Europe

Sertraline for system suitability

Iran Expo

Not Confirmed

04

EDQM, Council of Europe

Iran Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Sertraline for system suitability

CAS Number : 79559-97-0

Quantity Per Vial : 6.2 mg

Sale Unit : 1

Order Code : Y0000867

Batch No : 3

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!